CN
EN
DIFF CRO
Products and Services
DIFF CRO
「DIFF CRO」 is DIFF Biotech’s CRO service platform, leveraging proprietary recombinant viral vector technologies to provide innovative solutions for antiviral drug discovery, oncolytic virus development, gene therapy research, and next-generation vaccine development. Through advanced technology platforms and translational capabilities, 「DIFF CRO」 enables partners to accelerate biomedical innovation and development.
-
Neutralizing Antibody Detection ServicesHigh Sensitivity, Rapid Results
-
P2 Animal Evaluation ServicesFlexible, Compliant & Cost-Effective Solutions
-
P2 Virus Infection Animal ModelingInfluenza Virus Model, SARS-CoV-2 Pseudovirus Model, Respiratory Syncytial Virus (RSV) Model, Human Metapneumovirus (HMPV) Model, Herpes Simplex Virus (HSV) Model, Chikungunya Pseudovirus Model, Customizable Other Virus Models
-
In Vivo Animal-based Efficacy EvaluationAntiviral Drugs, Vaccines, Oncolytic Viruses
-
In Vitro Cell-based Efficacy EvaluationAntiviral Drugs, Vaccines, Oncolytic Viruses